Evogene (EVGN) Stock Forecast & Price Target

$2.58

+0.08 (+3.20%)

(As of 10/11/2024 08:50 PM ET)

Evogene - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 1 Analyst Ratings

Sell
0

Hold
0

Buy
1

Based on 1 Wall Street analysts who have issued ratings for Evogene in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for EVGN.

Consensus Price Target

$12.00
365.12% Upside

According to the 1 analysts' twelve-month price targets for Evogene, the average price target is $12.00. The highest price target for EVGN is $12.00, while the lowest price target for EVGN is $12.00. The average price target represents a forecasted upside of 365.12% from the current price of $2.58.

Get the Latest News and Ratings for EVGN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Evogene and its competitors.

EVGN Analyst Ratings Over Time

Type	Current Forecast 10/15/23 to 10/14/24	1 Month Ago 9/15/23 to 9/14/24	3 Months Ago 7/17/23 to 7/16/24	1 Year Ago 10/15/22 to 10/15/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$12.00	$15.25	$36.17	$36.17
Forecasted Upside	365.12% Upside	429.51% Upside	465.10% Upside	672.63% Upside
Consensus Rating	Buy	Buy	Buy	Buy

FREE investing Class TOMORROW + 2 FREE Bonuses (Ad)

Over the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stocks that outperform the market. It helps me understand which stocks are worth investing in now…AND which ones you should avoid at all costs! Tomorrow, during my LIVE intro to investing class online, my team will show you how exactly how it works

[YES, I'D LIKE TO REGISTER FOR CHARLES PAYNE'S UPCOMING INTRO TO INVESTING CLASS NOW!]

EVGN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EVGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Evogene Stock vs. The Competition

Type	Evogene	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.79	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	365.12% Upside	12,339.14% Upside	6.89% Upside
News Sentiment Rating	Positive News See Recent EVGN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
8/23/2024	Lake Street Capital 3 of 5 stars	Lower Target	Buy ➝ Buy	$30.00 ➝ $12.00	+238.03%
10/2/2023	Alliance Global Partners 1 of 5 stars	Initiated Coverage	Buy	$18.50	+215.43%
7/21/2023	Roth Mkm 1 of 5 stars	Boost Target	Buy	$10.00 ➝ $60.00	+430.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:20 AM ET.

EVGN Forecast - Frequently Asked Questions

: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Evogene is $12.00, with a high forecast of $12.00 and a low forecast of $12.00.
: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evogene in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EVGN shares.
: According to analysts, Evogene's stock has a predicted upside of 365.12% based on their 12-month stock forecasts.
: Evogene has been rated by research analysts at Lake Street Capital in the past 90 days.
: Analysts like Evogene more than other "medical" companies. The consensus rating for Evogene is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EVGN compares to other companies.